Fetal Growth Restriction (fgr) Clinical Trials
2 recruiting trials for Fetal Growth Restriction (fgr). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Fetal Growth Restriction (fgr) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Aristotle University Of Thessaloniki (1), Maxima Medical Center (1), among the most active sponsors registered for these trials.
Track Fetal Growth Restriction (fgr) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
The goal of this prospective cohort study is to examine how different parameters of assisted reproductive technologies (ART) are associated with the perinatal outcome in...
Amniotic Fluid & the Preterm Gut
Background: Necrotizing enterocolitis (NEC) and sepsis in preterm infants have been linked to intestinal immaturity and preclinical gut microbiota alterations. An important yet...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Fetal Growth Restriction (fgr), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Fetal Growth Restriction (fgr), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Fetal Growth Restriction (fgr), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.